BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 30196416)

  • 1. Generation of FLIP and FLIP-FlpE Targeting Vectors for Biallelic Conditional and Reversible Gene Knockouts in Mouse and Human Cells.
    Koo BK
    Methods Mol Biol; 2018; 1842():255-264. PubMed ID: 30196416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-step generation of conditional and reversible gene knockouts.
    Andersson-Rolf A; Mustata RC; Merenda A; Kim J; Perera S; Grego T; Andrews K; Tremble K; Silva JC; Fink J; Skarnes WC; Koo BK
    Nat Methods; 2017 Mar; 14(3):287-289. PubMed ID: 28135257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic Tagging of AGO1 Using CRISPR/Cas9-Mediated Homologous Recombination.
    Ghosh S; Liu JL
    Methods Mol Biol; 2018; 1680():217-235. PubMed ID: 29030852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombineering-based procedure for creating Cre/loxP conditional knockouts in the mouse.
    Bouvier J; Cheng JG
    Curr Protoc Mol Biol; 2009 Jan; Chapter 23():Unit 23.13. PubMed ID: 19170029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation and Characterization of a MYF5 Reporter Human iPS Cell Line Using CRISPR/Cas9 Mediated Homologous Recombination.
    Wu J; Hunt SD; Xue H; Liu Y; Darabi R
    Sci Rep; 2016 Jan; 6():18759. PubMed ID: 26729410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and Analysis of CCN Gene Activity Using CCN Knockout Mice Containing LacZ Reporters.
    Jiang J; Hu Z; Lyons KM
    Methods Mol Biol; 2017; 1489():325-345. PubMed ID: 27734387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of Genetic Knockouts in Myeloid Cell Lines Using a Lentiviral CRISPR/Cas9 System.
    Baker PJ; Masters SL
    Methods Mol Biol; 2018; 1714():41-55. PubMed ID: 29177854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic Tools for Self-Organizing Culture of Mouse Embryonic Stem Cells via Small Regulatory RNA-Mediated Technologies, CRISPR/Cas9, and Inducible RNAi.
    Takata N; Sakakura E; Sakuma T; Yamamoto T
    Methods Mol Biol; 2017; 1622():269-292. PubMed ID: 28674815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and Assembly of CRISPR/Cas9 Reagents for Gene Knockout, Targeted Insertion, and Replacement in Wheat.
    Čermák T; Curtin SJ
    Methods Mol Biol; 2017; 1679():187-212. PubMed ID: 28913802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homology arms of targeting vectors for gene insertions and CRISPR/Cas9 technology: size does not matter; quality control of targeted clones does.
    Petrezselyova S; Kinsky S; Truban D; Sedlacek R; Burtscher I; Lickert H
    Cell Mol Biol Lett; 2015 Dec; 20(5):773-87. PubMed ID: 26540224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene Targeted Mice with Conditional Knock-In (-Out) of NMDAR Mutations.
    Sprengel R; Eltokhi A; Single FN
    Methods Mol Biol; 2017; 1677():201-230. PubMed ID: 28986875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. User-Friendly Genetic Conditional Knockout Strategies by CRISPR/Cas9.
    Chen L; Ye Y; Dai H; Zhang H; Zhang X; Wu Q; Zhu Z; Spalinskas R; Ren W; Zhang W
    Stem Cells Int; 2018; 2018():9576959. PubMed ID: 30013601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Convenient Cas9-based Conditional Knockout Strategy for Simultaneously Targeting Multiple Genes in Mouse.
    Chen J; Du Y; He X; Huang X; Shi YS
    Sci Rep; 2017 Mar; 7(1):517. PubMed ID: 28364122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR-Cas9 enables conditional mutagenesis of challenging loci.
    Schick JA; Seisenberger C; Beig J; Bürger A; Iyer V; Maier V; Perera S; Rosen B; Skarnes WC; Wurst W
    Sci Rep; 2016 Sep; 6():32326. PubMed ID: 27580957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A method for the generation of conditional gene-targeted mice.
    Yamamoto M; Takeda K
    Methods Mol Biol; 2012; 757():399-410. PubMed ID: 21909924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An efficient method to generate conditional knockout cell lines for essential genes by combination of auxin-inducible degron tag and CRISPR/Cas9.
    Nishimura K; Fukagawa T
    Chromosome Res; 2017 Oct; 25(3-4):253-260. PubMed ID: 28589221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloning-free CRISPR.
    Arbab M; Srinivasan S; Hashimoto T; Geijsen N; Sherwood RI
    Stem Cell Reports; 2015 Nov; 5(5):908-917. PubMed ID: 26527385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Both TALENs and CRISPR/Cas9 directly target the HBB IVS2-654 (C > T) mutation in β-thalassemia-derived iPSCs.
    Xu P; Tong Y; Liu XZ; Wang TT; Cheng L; Wang BY; Lv X; Huang Y; Liu DP
    Sci Rep; 2015 Jul; 5():12065. PubMed ID: 26156589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new genetic tool to improve immune-compromised mouse models: Derivation and CRISPR/Cas9-mediated targeting of NRG embryonic stem cell lines.
    Martin Gonzalez J; Baudet A; Abelechian S; Bonderup K; d'Altri T; Porse B; Brakebusch C; Juliusson G; Cammenga J
    Genesis; 2018 Sep; 56(9):e23238. PubMed ID: 30010246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Precise in-frame integration of exogenous DNA mediated by CRISPR/Cas9 system in zebrafish.
    Hisano Y; Sakuma T; Nakade S; Ohga R; Ota S; Okamoto H; Yamamoto T; Kawahara A
    Sci Rep; 2015 Mar; 5():8841. PubMed ID: 25740433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.